Thermogenesis Ups Production of Cord Blood Stem Cell Processing Bags
by H.S. AyoubBioHealth Investor.com Thermogenesis (KOOL) announced early Friday that the company has increased its manufacturing capacity for the cord blood stem cell disposable bags for use with the AutoXpress system. The company can now produce as much as 2,000…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
by H.S. Ayoub
BioHealth Investor.com
Thermogenesis (KOOL) announced early Friday that the company has increased its manufacturing capacity for the cord blood stem cell disposable bags for use with the AutoXpress system.
The company can now produce as much as 2,000 disposable bag sets per week, or more than 100,000 per year.
In early February, the company released disappointing 2nd quarter numbers. Executives blamed a manufacturing capacity shortfall that caused a large backlog in orders of the disposable bags.
This latest announcement, if in fact is a fix, means that Thermogenesis could see enough days of increased production and sales prior to filing the next quarterly report.
http://www.biohealthinvestor.com/
Contact [email protected] for any questions or corrections.

